-
-
-
-
-
-
-
Candel Therapeutics, Inc. (CADL) Misses Q4 EPS by 29c
-
-
-
-
-
-
-
Candel Therapeutics secures $130 million term loan facility with Trinity Capital
-
-
-
-
-
-
-
Freedom Broker Starts Candel Therapeutics Inc. (CADL) at Buy
-
-
-
-
-
-
-
Candel Therapeutics (CADL) Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
-
-
-
-
-
-
-
Candel Therapeutics (CADL) and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
-
-
-
-
-
-
-
After-hours movers: Broadcom, Costco, EVgo, Candel Therapeutics
-
-
-
-
-
408,856 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

